Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

(2019) Martin Aringer et al.   Arthritis & Rheumatology

Antiphospholipid syndrome

(2019) Lisa R. Sammaritano   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort

(2016) F Conti et al.   LUPUS

Subclinical Atherosclerosis in Systemic Lupus Erythematosus and Antiphospholipid Syndrome

(2014) Fabrizio Conti et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Autoantibodies in pre-clinical autoimmune disease

(2014) Zhi-De Hu et al.   CLINICA CHIMICA ACTA

Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis

(2013) Laurent Arnaud et al.   AUTOIMMUNITY REVIEWS

Diagnosis and Classification of Diabetes Mellitus

(2013)   DIABETES CARE

Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: “Pros” and “Cons”

(2011) Fulvia Ceccarelli et al.   AUTOIMMUNITY REVIEWS

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

(2011) V. Pengo et al.   BLOOD

Antiphospholipid syndrome

(2010) Guillermo Ruiz-Irastorza et al.   LANCET

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients

(2007) T. Hereng et al.   LUPUS